Market Place
Sourcing Support
After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees
04 Mar 2022 //
ENDPTS
Pacira buys Flexion for $450M to boost pain offerings
12 Oct 2021 //
FIERCEPHARMA
Supernus and Pacira swoop while their targets are down
11 Oct 2021 //
EVALUATE
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
01 Oct 2021 //
GLOBENEWSWIRE
Flexion Announces Inclusion of ZILRETTA in AAOS Clinical Practice Guidelines
02 Sep 2021 //
GLOBENEWSWIRE
Flexion expands P1b Trial in FX301 for the Management of Post-Operative Pain
25 Aug 2021 //
GLOBENEWSWIRE
Flexion Therapeutics Reports Second-Quarter 2021 Financial Results
04 Aug 2021 //
GLOBENEWSWIRE
Flexion Therapeutics to Second-Quarter 2021 Financial Results on August 4, 2021
29 Jul 2021 //
GLOBENEWSWIRE
Flexion Announces Appointment of Utpal Koppikar to its Board of Directors
12 Jul 2021 //
GLOBENEWSWIRE
Flexion Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Jul 2021 //
GLOBENEWSWIRE
Flexion Reports First-Quarter 2021 Financial Results and Recent Business Updates
12 May 2021 //
GLOBENEWSWIRE
Flexion Therapeutics Announces Presentation of Preliminary FX201
28 Apr 2021 //
GLOBENEWSWIRE
Flexion Therapeutics Announces First Patient Treated in FX301 Phase 1b
31 Mar 2021 //
GLOBENEWSWIRE
Flexion scores WNBA star to rep for knee remedy Zilretta
04 Mar 2021 //
FIERCEPHARMA
Flexion Therapeutics Announces FDA Clearance of INDA for FX301
01 Mar 2021 //
GLOBENEWSWIRE
Flexion Therapeutics to Advance Investigational Gene Therapy FX201
18 Feb 2021 //
GLOBENEWSWIRE
Flexion Announces Preliminary, Unaudited Fourth-Quarter
13 Jan 2021 //
GLOBENEWSWIRE
Flexion Therapeutics Announces Preliminary Third-Quarter 2020 ZILRETTA®
13 Oct 2020 //
GLOBENEWSWIRE
Flexion Announces Podium Presentation of FX301 Preclinical Data
05 Oct 2020 //
GLOBENEWSWIRE
KEY TRIAL OF NOVEL OA GENE THERAPY DRUG LAUNCHED
16 Sep 2020 //
RYOTHRO
Flexion Announces Treatment of First Patient in Second Cohort of FX201
08 Sep 2020 //
GLOBENEWS WIRE
Flexion Therapeutics Announces Preliminary Second-Quarter 2020 ZILRETTA®
14 Jul 2020 //
GLOBENEWLSWIRE
Enforcement Report - Week of July 8, 2020
08 Jul 2020 //
FDA
Flexion`s Announces Publication of New Abstracts Accepted at Osteoarthritis
01 May 2020 //
GLOBENEWSWIRE
Flexion`s Announces Positive Preclinical Data Supporting Development of FX301
27 Apr 2020 //
FLEXIONTHERAPEUTICS
Flexion Therapeutics Announces ZILRETTA® License Agreement & Provides Business
01 Apr 2020 //
GLOBENEWSWIRE
Flexion Therapeutics stock soars 24% premarket as FDA approves label change for OA keen pain therapy
28 Dec 2019 //
MARKET WATCH
Flexion Therapeutics Enrolls First Patients in Phase 2 Trial of ZILRETTA
17 Dec 2019 //
BIO SPACE
